Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank38
3Y CAGR+14.8%
5Y CAGR-35.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+14.8%/yr
vs -47.3%/yr prior
5Y CAGR
-35.4%/yr
Recent acceleration
Acceleration
+62.2pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.90 | +80.4% |
| 2024 | 4.93 | +18.7% |
| 2023 | 4.15 | -29.3% |
| 2022 | 5.88 | -77.0% |
| 2021 | 25.52 | -67.6% |
| 2020 | 78.86 | +80.3% |
| 2019 | 43.73 | -42.7% |
| 2018 | 76.33 | -30.9% |
| 2017 | 110.51 | - |